Insmed Inc (INSM)

NASDAQ
Currency in USD
Disclaimer
16.80
-0.34
(-1.98%)
Real-time Data
Day's Range
16.74
17.40
52 wk Range
16.04
28.94
Volume
321,099
Prev. Close
17.14
Open
17.2
Day's Range
16.74-17.4
52 wk Range
16.04-28.94
Volume
321,099
Average Vol. (3m)
1,300,146
1-Year Change
-26.09%
Shares Outstanding
136,405,367
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

People Also Watch

18.04
RGNX
-4.80%
47.91
PTCT
-0.57%
22.67
AGIO
-1.99%

Insmed Inc News

Insmed Inc Analysis

Insmed Inc Company Profile

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.